I agree that this site is using cookies. You can find further informations here.
X
Bollaerts, Kaatje
101  results:
Search for persons X
?
1

The role of real-world evidence for regulatory and public h..:

Bollaerts, Kaatje ; Wyndham-Thomas, Chloé ; Miller, Elizabeth...
Biologicals.  85 (2024)  - p. 101750 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Protection against COVID-19 hospitalisation conferred by pr..:

Meeraus, Wilhelmine ; de Munter, Leonie ; Gray, Christen M....
The Lancet Regional Health - Europe.  31 (2023)  - p. 100675 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Vaccination programmes 

epidemiology, monitoring, evaluation 
Hahné, Susan ; Farrington, Paddy ; Bollaerts, Kaatje , 2022
Link: https://doi.org/10.4324/..
 
?
4

Evaluation of Heterologous Effects of Travel Vaccines in Co..:

Herweijer, Eva ; Schwamborn, Klaus ; Bollaerts, Kaatje...
Gastro Hep Advances.  1 (2022)  4 - p. 531-537 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Vaccination programmes: epidemiology, monitoring, evaluatio:

Hahné, Susan ; Farrington, Paddy ; Bollaerts, Kaatje , 2022
Link: https://search.ebscohost..
 
?
6

Public health impact of low-dose aspirin on colorectal canc..:

Biccler, Jorne ; Bollaerts, Kaatje ; Vora, Pareen...
IJC Heart & Vasculature.  36 (2021)  - p. 100851 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Vaccine-Preventable Disease Incidence Based on Clinically, ..:

Bollaerts, Kaatje ; Fletcher, Mark A ; Suaya, Jose A...
Clinical Infectious Diseases.  74 (2021)  8 - p. 1362-1371 , 2021
Link: https://doi.org/10.1093/..
 
?
8

European data sources for computing burden of (potential) v..:

Méroc, Estelle ; Fröberg, Janeri ; Almasi, Timea...
BMC Infectious Diseases.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
9

Preventing infectious diseases for healthy ageing: The VITA..:

Van Baarle, Debbie ; Bollaerts, Kaatje ; Del Giudice, Giuseppe...
Vaccine.  38 (2020)  37 - p. 5896-5904 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Outcome misclassification: Impact, usual practice in pharma..:

Hall, Gillian C. ; Lanes, Stephan ; Bollaerts, Kaatje...
Pharmacoepidemiology and Drug Safety.  29 (2020)  11 - p. 1450-1455 , 2020
Link: https://doi.org/10.1002/..
 
?
11

ADVANCE system testing: Can coverage of pertussis vaccinati..:

Emborg, Hanne-Dorthe ; Kahlert, Johnny ; Braeye, Toon...
Vaccine.  38 (2020)  - p. B22-B30 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Benefit–Risk Assessment of Vaccines. Part I: A Systematic R..:

Arlegui, Hugo ; Bollaerts, Kaatje ; Salvo, Francesco...
Drug Safety.  43 (2020)  11 - p. 1089-1104 , 2020
Link: https://doi.org/10.1007/..
 
?
13

Disease misclassification in electronic healthcare database..:

Bollaerts, Kaatje ; Rekkas, Alexandros ; De Smedt, Tom...
PLOS ONE.  15 (2020)  4 - p. e0231333 , 2020
Link: https://doi.org/10.1371/..
 
?
14

ADVANCE: Towards near real-time monitoring of vaccination c..:

Bollaerts, Kaatje ; de Smedt, Tom ; McGee, Chris...
Vaccine.  38 (2020)  - p. B76-B83 , 2020
Link: https://doi.org/10.1016/..
 
?
15

ADVANCE system testing: Benefit-risk analysis of a marketed..:

Bollaerts, Kaatje ; Ledent, Edouard ; de Smedt, Tom...
Vaccine.  38 (2020)  - p. B65-B75 , 2020
Link: https://doi.org/10.1016/..
 
1-15